
PMM2-CDG - Symptoms, Causes, Treatment | NORD
2015年8月6日 · PMM2-CDG is caused by mutations of the phosphomannomutase-2 (PMM2) gene and is inherited as an autosomal recessive condition. PMM2-CDG belongs to a group of disorders known as the congenital disorders of glycosylation (CDG). CDG were first reported in the medical literature in 1980 by Dr. Jaak Jaeken, et al.
PMM2-CDG - GeneReviews® - NCBI Bookshelf
2005年8月15日 · PMM2-CDG, the most common of a group of disorders of abnormal glycosylation of N-linked oligosaccharides, is divided into three clinical stages: infantile multisystem, late-infantile and childhood ataxia–intellectual disability, and adult stable disability.
PMM2-congenital disorder of glycosylation - MedlinePlus
PMM2 -congenital disorder of glycosylation (PMM2 -CDG, also known as congenital disorder of glycosylation type Ia) is an inherited condition that affects many parts of the body. The type and severity of problems associated with PMM2 -CDG vary widely among affected individuals, sometimes even among members of the same family.
PMM2 deficiency - Wikipedia
PMM2 deficiency or PMM2-CDG, previously CDG-Ia, is a very rare genetic disorder caused by mutations in PMM2. It is an autosomal recessive disease that is the most common type of congenital disorder of glycosylation or CDG. [2] PMM2-CDG is the most common of a growing family of more than 130 extremely rare inherited metabolic disorders. [3] Only about 800 children and adults have been reported ...
PMM2-congenital disorder of glycosylation | About the Disease
PMM2-congenital disorder of glycosylation is caused by genetic mutations, also known as pathogenic variants. Genetic mutations can be hereditary, when parents pass them down to their children, or they may occur randomly when cells are dividing.
磷酸甘露糖变位酶2缺乏症的诊治进展 - PMC
磷酸甘露糖变位酶2缺乏症是最常见的N-糖基化障碍,又称磷酸甘露糖变位酶2相关性先天性糖基化障碍(phosphomannomutase 2-congenital disorder of glycosylation,PMM2-CDG),是一种常染色体隐性遗传的多系统疾病,由PMM2基因(OMIM:601785)突变所致,病情轻重不一,目前尚 …
International clinical guidelines for the management of ...
Phosphomannomutase 2 (PMM2-CDG) is the most common congenital disorder of N-glycosylation and is caused by a deficient PMM2 activity. The clinical presentation and the onset of PMM2-CDG vary among affected individuals ranging from a severe antenatal presentation with multisystem involvement to mild …
PMM2-congenital disorder of glycosylation - National …
The most frequent form of congenital disorder of N-glycosylation and is characterized by cerebellar dysfunction, abnormal fat distribution, inverted nipples, strabismus and hypotonia. 3 forms of PMM2-CDG can be distinguished: the infantile multisystem type, late-infantile and childhood ataxia-intellectual disability type (3-10 yrs old), and the ...
Orphanet: PMM2-CDG
A rare congenital disorder of N-glycosylation and is characterized by cerebellar dysfunction, abnormal fat distribution, inverted nipples, strabismus and hypotonia. 3 forms of PMM2-CDG can be distinguished: the infantile multisystem type, late-infantile and childhood ataxia-intellectual disability type (3-10 yrs old), and the adult stable ...
PMM2-CDG - PubMed
2021年5月20日 · Clinical characteristics: PMM2-CDG, the most common of a group of disorders of abnormal glycosylation of N-linked oligosaccharides, is divided into three clinical stages: infantile multisystem, late-infantile and childhood ataxia–intellectual disability, and …
- 某些结果已被删除